Method of treating eye infections with azithromycin

a technology of azithromycin and eye infections, applied in the field of eye infections, can solve the problems of not being effective when topically applied to the eye, antibiotics which are effective when administered by a systemic route are not necessarily effective when applied topically, and the effect of high and sustained levels in the eye is expected to be significant enhanced, and the effect of effective drug levels

Inactive Publication Date: 2005-07-28
PFIZER INC
View PDF12 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Until the present invention, however, azithromycin was not known to be effective when topically administered to the eye.
However, it is also known that antibiotics which are effective when administered by a systemic route are not necessarily effective when applied topically, directly to the eye.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0013] A preferred embodiment was prepared by incorporating 5 g of azithromycin dihydrate into 995 g of a sterile vehicle comprising 55% by weight of petrolatum, 43% by weight of light mineral oil, and 2% by weight of lanolin. The procedure involved first heating an excess amount of the ointment vehicle of the aforementioned composition to 70° C. in a glass vessel to produce a melt. In the next step, 995 g of the molten sterile ointment was transferred into a compounding vessel equipped with a mixer and 5 g of the azithromycin hydrate was added to the melt under agitation at 70° C. to form a suspension. The azithromycin containing ointment was rapidly cooled by placing the compounding vessel in an ice bath. The “0.5% azithromycin ointment” was then filled into 1 cc unit dose plastic syringes for dose application. This ointment may be sterilized by gamma radiation using a cobalt-60 source.

example 2

[0014] A 0.5 weight percent azithromycin dihydrate opthalmic solution is prepared by dissolving 50 g of azithromycin dihydrate (0.5 weight %), 67.0 g (0.67 weight percent) boric acid, 20.7 g (0.207 weight percent) sodium borate decahydrate, 100 g (1.0 weight percent) glycerin, 100 g of polyethylene glycol 300 (1.0 weight percent), and 0.40 g (0.004 weight percent) thimerosal (as a preservative) in about 8000 g of deionized distilled water. The pH is adjusted to 7.2 with HCl and NaOH. The final batch weight is brought to 10,000 g with the addition of the required amount of water. The final solution is filtered through a 0.2 micron Millipore filter and filtered into vials.

example 3

[0015] In a preferred embodiment, an approximate 0.5 weight percent azithromycin dihyrate opthalmic suspension is prepared as follows: 600 g of petrolatum is heated to 90° C. for 2 hours in a jacketed 316 stainless steel vessel. The temperature is then decreased to 60° C. Light mineral oil, 350 g, is added to the petrolatum under mild agitation. The solution is passed through a sintered glass filter. Azithromycin dihyrate, 5 g, is dispersed into the mineral oil / petrolatum solution under agitation to form a finely dispersed suspension. The suspension is cooled under slow agitation to form a semisolid suspension. The suspension is filled into plastic, polypropylene tubes and sterilized by gamma radiation using a cobalt-60 source.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
weight %aaaaaaaaaa
weight %aaaaaaaaaa
weightaaaaaaaaaa
Login to view more

Abstract

The invention features methods and compositions for treating ocular infections. The method comprises topically administering to an eye of an animal in need of such treatment an ocular infection-treating amount of azithromycin.

Description

FIELD OF THE INVENTION [0001] This invention relates to methods of treating eye infections by topically administering azithromycin to an eye of an animal in need of such treatment. BACKGROUND OF THE INVENTION [0002] Azithromycin is the U.S.A.N. (generic name) for 9a-aza-9a-methyl-9-deoxo-9a-homoerythromycin A, a broad spectrum antimicrobial compound derived from erythromycin A. Azithromycin is disclosed in U.S. Pat. No. 4,474,768 to Bright and U.S. Pat. No. 4,517,359 to Kobrehel et al. These patents disclose that azithromycin and certain derivatives thereof possess antibacterial properties and are accordingly useful as antibiotics. [0003] Azithromycin is commonly administered orally, in a number of different dosage forms such as tablets, capsules, and suspensions, for the treatment of antibacterial infections. Until the present invention, however, azithromycin was not known to be effective when topically administered to the eye. Azithromycin is known to be effective for the treatmen...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/7048
CPCA61K31/7048
Inventor AHMED, IMRAN
Owner PFIZER INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap